Citadel Advisors »

Lyra Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 2.9M 5.24
2023-09-30 $11M 2.9M 3.91
2023-06-30 $12M 2.9M 4.11
2023-03-31 $26k 13k 2.07
2022-12-31 $82k 26k 3.14
2021-12-31 $58k 13k 4.38
2021-06-30 $156k 19k 8.05
2020-06-30 $2.9M 256k 11.34